Finance

Lists
HCA:NYSE
HCA Healthcare Inc
USD 451,09
+1,37%
(+6,08) 1D
9 Okt., 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HCA...
Open
USD 444,58
High
USD 452,39
Low
USD 442,32
Mkt. cap
97,66 mjd
Avg. vol.
1,38 m
Volume
0,00
Dividend
0,69%
Quarterly dividend
USD 0,78
Ex-dividend date
16 Sep. 2026
P/E ratio
15,10
52-wk high
USD 556,52
52-wk low
USD 353,99
EPS
USD 29,87
Beta
1,11
Shares outstanding
216,50 m
No. of employees
275 k
Open
USD 444,58
High
USD 452,39
Low
USD 442,32
Mkt. cap
97,66 mjd
Avg. vol.
1,38 m
Volume
0,00
Dividend
0,69%
Quarterly dividend
USD 0,78
Ex-dividend date
16 Sep. 2026
P/E ratio
15,10
52-wk high
USD 556,52
52-wk low
USD 353,99
EPS
USD 29,87
Beta
1,11
Shares outstanding
216,50 m
No. of employees
275 k
News stories
From web sources and news partners
Profile
HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors. Wikipedia
About HCA Healthcare Inc
CEOSamuel N. Hazen
Employees275 k
Founded1968
HeadquartersNashville, Tennessee, Verenigde State van Amerika
SectorHealth care provider
Analyst ratings
Based on 22 analysts giving stock ratings to HCA in the past 3 months
Buy
Buy
14
Hold
7
Sell
1
12-month forecast
Based on 22 Wall Street analysts offering 12 month price targets for HCA in the last 3 months.
Highest
Current USD 451,09
USD 579,00 (+28,36%)
Average
USD 457,20 (+1,35%)
Lowest
USD 380,00 (-15,76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ben Hendrix
RBC Capital
Buy
Maintained
USD 496,00
+10%
10/07/2026
Andrew Mok CFA
Barclays
Hold
Maintained
USD 387,00
-14,2%
10/07/2026
Lance Wilkes
Bernstein
Hold
Maintained
USD 426,00
-5,6%
10/05/2026
Andrew Cooper
Raymond James
Hold
Reiterated
-
-
09/28/2026
Sean Dodge
BMO Capital
Buy
Initiated
USD 495,00
+9,7%
09/22/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
-
-
09/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
USD 450,00
-0,2%
09/17/2026
Benjamin Rossi
J.P. Morgan
Hold
Maintained
USD 425,00
-5,8%
08/24/2026
Kevin Fischbeck
Bank of America Securities
Hold
Reiterated
USD 425,00
-5,8%
08/10/2026
Unknown Analyst
Argus Research
Buy
Maintained
USD 500,00
+10,8%
08/07/2026
David Toung
Argus Research
Buy
Reiterated
USD 500,00
+10,8%
08/07/2026
David S Macdonald
Truist Financial
Buy
Reiterated
USD 495,00
+9,7%
08/05/2026
Stephen Baxter
Wells Fargo
Hold
Reiterated
USD 381,00
-15,5%
08/03/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
USD 475,00
+5,3%
07/28/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
USD 485,00
+7,5%
07/27/2026
A.J. Rice
UBS
Buy
Maintained
USD 579,00
+28,4%
07/27/2026
Pito Chickering
Deutsche Bank
Buy
Reiterated
USD 476,00
+5,5%
07/27/2026
Craig Hettenbach
Morgan Stanley
Sell
Maintained
USD 380,00
-15,8%
07/27/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
USD 485,00
+7,5%
07/27/2026
Michael Ha
Robert W. Baird
Hold
Maintained
USD 393,00
-12,9%
07/27/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
USD 435,00
-3,6%
07/27/2026
Ryan Langston
TD Cowen
Buy
Reiterated
USD 431,00
-4,5%
07/27/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
USD 525,00
+16,4%
07/14/2026
Unknown Analyst
Stephens
Buy
Reiterated
USD 530,00
+17,5%
04/27/2026
Raj Kumar CFA
Stephens
Buy
Reiterated
USD 530,00
+17,5%
04/27/2026
Courtney Breen
Bernstein
Hold
Maintained
USD 541,00
+19,9%
03/30/2026
Last report
24 Jul. 2026
Fiscal period
Q2 2026
USD 7,59 / USD 7,50
+1,23%beat
Revenue / Est. (USD)
20,23 mjd / 19,74 mjd
+2,46%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
19,16 mjd
19,51 mjd
19,11 mjd
20,23 mjd
Cost of goods sold
11,15 mjd
11,34 mjd
11,14 mjd
11,18 mjd
Cost of revenue
11,15 mjd
11,34 mjd
11,14 mjd
11,18 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
1,03 mjd
-
-
Operating expense
5,05 mjd
5,00 mjd
5,11 mjd
5,99 mjd
Total operating expenses
16,20 mjd
16,34 mjd
16,25 mjd
17,16 mjd
Operating income
2,96 mjd
3,18 mjd
2,86 mjd
3,07 mjd
Other non operating income
-
-
-
-
EBT including unusual items
2,42 mjd
2,67 mjd
2,29 mjd
2,49 mjd
EBT excluding unusual items
2,42 mjd
2,63 mjd
2,29 mjd
2,48 mjd
Income tax expense
515,00 m
509,00 m
430,00 m
564,00 m
Effective tax rate
21,30%
19,05%
18,80%
22,61%
Other operating expenses
4,16 mjd
3,06 mjd
4,18 mjd
5,04 mjd
Net income
1,64 mjd
1,88 mjd
1,62 mjd
1,70 mjd
Net profit margin
8,57%
9,62%
8,48%
8,40%
Earnings per share
6,96
8,01
7,15
7,59
Interest and investment income
-
-
-
-
Interest expense
-561,00 m
-572,00 m
-584,00 m
-599,00 m
Net interest expenses
-561,00 m
-572,00 m
-584,00 m
-599,00 m
Depreciation and amortization charges
889,00 m
911,00 m
930,00 m
944,00 m
EBITDA
3,85 mjd
4,09 mjd
3,79 mjd
4,01 mjd
Gain or loss from assets sale
2,00 m
-41,00 m
1,00 m
-10,00 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme